top of page
Retreats 2021
Retreats 2021
​
Palliative Nexus
Improving equity, access, and quality of care in serious illness
​
​
Key Aim
To evaluate two pain relief medications, oxycodone/naloxone prolonged-release (OXN PR) and oxycodone alone prolonged-release (Oxy PR) with respect to analgesic efficacy and constipation in patients with advanced cancer.
Principal Investigator
Dr Aaron Wong, Peter MacCallum Cancer Centre
Additional information
//www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=377673&isReview=true
Funding
Mundipharma
​
Enhance: A multi-centre, randomised, phase IV study to compare the efficacy of oxycodone/naloxone verses oxycodone prolonged release tablets in patients with advanced cancer
​
bottom of page